Clinical Trial Update: Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data

View source ↗

Summary

This clinical trial update indicates that the study evaluating the Mjn-SERAS Solution for epilepsy-related quality of life and safety in treatment-refractory ep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Mjn-SERAS Solution

Snippet

Sponsor: MJN Neuroserveis, S.L | Conditions: Quality of Life, Epilepsy (treatment Refractory) | Status: RECRUITING